Insider Transactions in Q2 2024 at Myriad Genetics Inc (MYGN)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 06
2024
|
Daniel Skovronsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,695
+15.43%
|
-
|
|
Jun 06
2024
|
Paul Bisaro Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,695
+28.11%
|
-
|
|
Jun 06
2024
|
S. Louise Phanstiel Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,695
+10.95%
|
-
|
|
Jun 06
2024
|
Colleen F Reitan Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,695
+15.06%
|
-
|
|
Jun 06
2024
|
Rashmi Kumar Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,695
+15.6%
|
-
|
|
Jun 06
2024
|
Lee Nisley Newcomer Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,695
+16.01%
|
-
|
|
Jun 06
2024
|
Heinrich Dreismann Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,695
+10.65%
|
-
|
|
Jun 04
2024
|
Daniel K Spiegelman Director |
SELL
Open market or private sale
|
Direct |
3,788
-10.32%
|
$83,336
$22.05 P/Share
|
|
Jun 03
2024
|
Daniel K Spiegelman Director |
SELL
Open market or private sale
|
Direct |
3,788
-9.35%
|
$83,336
$22.04 P/Share
|
|
May 15
2024
|
Paul J Diaz President and CEO |
SELL
Open market or private sale
|
Direct |
75,000
-6.57%
|
$1,875,000
$25.07 P/Share
|
|
May 14
2024
|
Paul J Diaz President and CEO |
SELL
Open market or private sale
|
Direct |
95,000
-7.69%
|
$2,375,000
$25.21 P/Share
|
|
May 13
2024
|
Paul J Diaz President and CEO |
SELL
Open market or private sale
|
Direct |
57,844
-4.47%
|
$1,446,100
$25.13 P/Share
|
|
May 13
2024
|
Lee Nisley Newcomer Director |
SELL
Open market or private sale
|
Direct |
6,200
-8.51%
|
$155,000
$25.3 P/Share
|
|
Apr 14
2024
|
Mark Verratti Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,076
-0.36%
|
$20,444
$19.55 P/Share
|
|
Apr 14
2024
|
Dale Muzzey Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
940
-0.85%
|
$17,860
$19.55 P/Share
|
|
Apr 06
2024
|
Natalie Munk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
581
-1.29%
|
$11,620
$20.26 P/Share
|